Secondary Logo

Institutional members access full text with Ovid®

Long-term Challenges After Solid Organ Transplantation: Summary of Expert Presentations From the Sandoz 5th Standalone Transplantation Meeting, 2017

Legendre, Christophe, MD1; Viebahn, Richard, MD, PhD2; Fehrman-Ekholm, Ingela, MD, PhD3; Masnou, Núria, MD4; Berenguer, Marina, MD5; Potena, Luciano, MD, PhD6; Wennberg, Lars, MD, PhD3; O’Grady, John, MD7; Epailly, Eric, MD8; Diekmann, Fritz, MD, PhD9; Binet, Isabelle, MD10; Schwenger, Vedat, MD11; Kuypers, Dirk, MD, PhD12; Guthoff, Martina, PhD13

doi: 10.1097/TP.0000000000002316

1 Université Paris Descartes and Necker Hospital, Paris, France.

2 Ruhr-University of Bochum and Universitätsklinikum Knappschaftskrankenhaus Bochum, Germany.

3 Karolinska University Hospital, Stockholm, Sweden.

4 University Hospital Dr. Josep Trueta of Girona, Catalogne, Spain.

5 La Fe University Hospital and University of Valencia, Valencia, Spain.

6 Bologna Academic Hospital, Bologna, Italy.

7 King’s College Hospital, London, United Kingdom.

8 University Hospital of Strasbourg, Strasbourg, France.

9 University of Barcelona, Barcelona, Spain.

10 Cantonal Hospital, St Gallen, Switzerland.

11 Heidelberg University, Stuttgart, Germany.

12 University Hospitals Leuven, Leuven, Belgium.

13 Eberhard Karls University Tübingen, Tübingen, Germany.

Received 15 February 2018. Revision received 10 May 2018.

Accepted 18 May 2018.

I.F. received funding from Gelin Foundation, Foundation for the Kidney Disease, Foundation of Hobohm. M.B. received grant: Gilead/Speaker: Abbvie, Gilead, MSD, Astellas, Novartis, Sandoz. L.P. received speaker's fees from: Novartis, Qiagen, One Lambda; Institutional grant from Qiagen. I.B. received funding from Alexion, Astellas, Baxter, Bayer, Böhringer-Ingelheim, Fresenius, Lophius, Vifor. V.S. received speaking honoraria: Amgen, Baxter, FMC, Hexal/Sandoz, Novartis. D.K. received research grants from Astellas, Novartis and Roche. DK received speaker’s fees and travel grants from Astellas, Novartis and Sandoz. M.G. received research support: Novartis, and speaker's fees: Alexion, Baxter, Hexal/Sandoz, Novartis. Travel grants: Alexion, Astellas, Chiesi, Pfizer, Teva.

I.F.-E. have been in the board of Glycorex AB and received lecture fees from Amgen, Astellas, Alexion, Sandoz-Novartis and Roche. L.W. is a clinical studies investigator Astellas, Alexion, Novartis, Genentech, Chiesi, Hansa Medical, BMS. Advisory board in Sandoz, Chiesi. Invited speaker, Sandoz, Neovii.

The content of the slides presented at this meeting was prepared independently by each presenter. Each author reviewed the subsequent meeting report. This standalone meeting was organized and funded by Sandoz International GmbH, all speakers were provided an honoraria for presenting at the meeting and delegate expenses were paid to attend the meeting. The supplement has been supported by Sandoz International GmbH. Approval code: D11807858066.

Correspondence: Christophe Legendre, MD, PhD, Hôpital Necker, 149, rue de Sèvres 75015 Paris France. (; Richard Viebhan, MD, PhD, Ruhr-University of Bochum and Universitätsklinikum Knappschaftskrankenhaus Bochum, Germany. (

Copyright © 2018 Wolters Kluwer Health, Inc. All rights reserved.